Last year, Ranbaxy had paid around $4,20,000 to the US state of Idaho as part of a $500-million settlement that the drug firm had signed with US authorities.
Among these, Hindalco and Vedanta from the metal pack have become multi-baggers, gaining 100 per cent in 2016
Indian drugmaker Dr Reddy's Laboratories hopes to launch two-to-three generic products in the United States this year in a bid to increase its share of a lucrative market, its chief executive said.
Indian drug maker Alembic Ltd plans to expand its bulk drugs business in the United States by joining hands with US formulations makers, the Bombay Stock Exchange said on Thursday.
Indian drugmaker Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to market an oral suspension form of Warner Chilcott's Duricef antibiotic, the Bombay Stock Exchange
While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.
Have conviction in your bets and use stop-loss as a defence mechanism to curtail losses.
India on Monday raised serious concerns over the USFDA's audit inspections of Indian pharma companies and 'disproportionate penalties' in some instances and said it would submit a discussion document on the issues to the US.
Drugmaker Dr Reddy's Laboratories has filed an application with the US Food and Drug Administration to market a generic form of Eli Lilly's schizophrenia drug Olanzapine in the US
'The focus for value creation will be on all business segments.'
Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.
Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.
Some eyewitnesses alleged that the victims suffered bullet wounds but district authorities denied that there was any firing by police
The winter session of Parliament will commence on November 26.
Analysts say those taking exposure through stocks could look at firms focused on domestic business
Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.
TCS, Infosys and Wipro were down 0.4-2% each. Capital goods majors also ended lower with L&T and BHEL down 1.4-3.9% each.
The past eight months have seen vast improvement in the Indian economy, says Edelweiss Group chairman and chief executive Rashesh Shah, who feels domestic-oriented sectors are likely to do better.
Swapnil Bajpai, 32, from Jalandhar, Punjab tells us about his 17 years of friendship with his best buddy Nikhil who currently resides in Dubai.
Broader markers outperformed their larger peers.
Gains were led by Tata Motors amid robust sales in June along with select financials.
Upset over the Devyani Khobragade episode, India on Wednesday raised with the United States its concerns over "trafficking" visas issued to family members of Sangita Richard, the absconding maid of the Indian diplomat whose arrest had triggered a row between the two countries.
The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.
Experts suggest six ways to play stocks that tank suddenly and make money as Sanjay Kumar Singh listens in
Cipla, though late in changing its strategy for international markets, has in recent years taken an inorganic route for expansion.
Formal warning to Indian unit of deficiencies noted during inspection at facility near Chennai; firm says will remedy
Takeda had filed a case of patent infringement in response to Zydus' abbreviated new drug application.
Domestic food companies, too, continue to bet on packaged foods.
The Supreme Court on Monday posed some tough questions to a lawyer, asking him to substantiate his "unfounded allegations" in a PIL that Indian pharma major Ranbaxy Laboratories Ltd was allegedly manufacturing and selling adulterated medicines.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
While larger companies like Nestle India, Britannia and the like are often mentioned, some mid-cap companies are also expected to grow at a rapid clip.
The top gainers on the Sensex are Gail(India), HDFC, Infosys.
.jpg)
To focus on molecules at advanced stage of development; move to impact 200 scientists.
The report said that India maintains zero-tolerance standards for certain plant quarantine pests, such as weed seeds and ergot.
The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.
'Indian doctors have also been wary of patients learning about drugs and brand names.' 'Probably harking back to the Brahmanical tradition of preserving information and knowledge from getting polluted by the lower classes,' says Ambi Parameswaran.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances